June 6, 2011 (Washington, DC) — A post hoc analysis of a phase 3 clinical trial of the acute migraine drug dihydroergotamine (Levadex, MAP Pharmaceuticals Inc) using 4 different previously published ...
Prostate-specific antigen (PSA) defined biochemical recurrence (BCR) of prostate cancer is widely used for reporting the outcome of radical prostatectomy (RP). A standardized BCR definition is lacking ...
The American Society for Therapeutic Radiology and Oncology (ASTRO) definition of biochemical recurrence in prostate cancer has several recognized limitations. The Phoenix definition of biochemical ...
To determine whether a variable definition of biochemical recurrence (BCR) based on clincopathologic features facilitates early identification of patients likely to suffer from disease progression.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback